Your browser doesn't support javascript.
loading
Unrelated cord blood transplantation using minimal-intensity conditioning in a 1.5-month-old infant with X-linked severe combined immunodeficiency.
Takeuchi, Shio; Shigemura, Tomonari; Shigeto, Shohei; Murase, Tsubasa; Morita, Daisuke; Motobayashi, Mitsuo; Takashi, Kurata; Kobayashi, Norimoto; Agematsu, Kazunaga; Nakazawa, Yozo.
Afiliação
  • Takeuchi S; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
  • Shigemura T; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan; Department of Pediatrics, National Hospital Organization Matsumoto National Hospital, Matsumoto, Japan. Electronic address: tomonari707@gmail.com.
  • Shigeto S; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
  • Murase T; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
  • Morita D; Department of Hematology/Oncology, Nagano Children's Hospital, Azumino, Japan.
  • Motobayashi M; Department of Neurology, Nagano Children's Hospital, Azumino, Japan.
  • Takashi K; Department of Hematology/Oncology, Nagano Children's Hospital, Azumino, Japan.
  • Kobayashi N; Department of Pediatrics, Nagano Red Cross Hospital, Wakasato, Nagano, Japan.
  • Agematsu K; Department of Molecular and Cellular Immunology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakazawa Y; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Transpl Immunol ; : 102115, 2024 Sep 02.
Article em En | MEDLINE | ID: mdl-39233094
ABSTRACT

BACKGROUND:

Severe combined immunodeficiency (SCID) is a heterogenous disorder with profound deficiency of T/B-cell functions. The best SCID therapy requires hematopoietic stem cell transplantation (HSCT) early in life. HSCT with conditioning is necessary to achieve a long-term reconstitution of B-cell functions. However, conditioning may aggravate pre-existing infection and cause transplant-related toxicity, especially in very young infants. Hence, the intensity of conditioning should be reduced to allow the reconstitution of immunity including B cells to the extent that prevents transplant-related toxicity and delayed complications.

METHODS:

An infant with a family history of X-linked SCID (X-SCID) was diagnosed with X-SCID disorder soon after birth. The infant exhibited cytomegalovirus (CMV) infection despite being strictly isolated. At 1.5 months of age, we performed an unrelated cord blood transplantation (CBT) with a less intensity conditioning regimen fludarabine (125 mg/m2) + melphalan (80 mg/m2). We evaluated the efficacy of reconstitution by assessing B-cell function and growth and psychomotor development at 5 years and 7 months after CBT.

RESULTS:

The clinical course after CBT was uneventful after CBT. The CMV infection was fully controlled by ganciclovir or foscavir therapy, which was discontinued at day 55 after CBT. Furthermore, immunoglobulin (Ig) replacement therapy was also discontinued at 6 months after CBT. A sufficient proportion of CD27+ memory B cells was developed, which was essential for an effective vaccination and prevention of infections. While the B-cell chimerism became recipient-dominant, the Ig replacement therapy was substituted by very successful post-vaccine immunity acquisition after CBT. The analysis of the general developmental parameters showed that chemotherapy did not cause any delay in growth and psychomotor development.

CONCLUSIONS:

The CBT therapy with this conditioning regimen was well tolerated and induced an effective reconstitution of B-cell functions in an X-SCID infant under the 3 months of age.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transpl Immunol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transpl Immunol Ano de publicação: 2024 Tipo de documento: Article